Session Type
Meeting
Search Results for Checkpoint inhibitor
Abstract Number: N1
SHM Converge 2022
Case Presentation: A 76-year-old male with metastatic renal cell carcinoma presented to the hospital due to multiple syncopal episodes. The patient was prescribed pembrolizumab by infusion every 3 weeks (last dose was a week and a half prior). His presenting vitals were significant for a heart rate of 30 beats per minute and systolic blood […]
Abstract Number: 350
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Case Presentation: A 70 year old female with metastatic melanoma presented to the emergency department with fatigue and lethargy for one month. She had recently completed 6 cycles of Nivolumab and Ipilimumab and was currently receiving Nivolumab monotherapy. Over the past month, she had worsening fatigue associated with nausea and decreased appetite. Lab work one […]
Abstract Number: 442
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Case Presentation: We are presenting a case of a 71-year-old male patient with a history of hypertension, non-insulin dependent type 2 diabetes mellitus (DM) well controlled on metformin, and non-invasive high grade urothelial bladder cancer diagnosed in 2014 treated with transurethral resection of the prostate and intravesicular mitomycin. In 2016, his bladder cancer has progressed […]
Abstract Number: 444
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Case Presentation: A 70 year old male with metastatic malignant melanoma on immunotherapy with nivolumab and ipilimumab was sent to the hospital by his oncologist for abdominal pain and elevated liver enzymes. His labs were notable for AST 275, ALT 1138, alkaline phosphatase of 394 and total bilirubin of 3.94. This patient had no known […]
Abstract Number: 484
SHM Converge 2021
Case Presentation: A 78 year old man with recurrent metastatic adenosquamous lung carcinoma (recently initiated pembrolizumab), CAD s/p CABG, HTN, DM2, and HLD, presented with 2 weeks of fatigue, myalgias, anorexia, and weakness acutely worsening in the prior 2 days. He had no fever, chills, chest pain, dyspnea, orthopnea, palpitations, or lower extremity edema. ED […]
Abstract Number: 485
SHM Converge 2021
Case Presentation: Immunotherapy is an emerging therapeutic option in the field of oncology. Dermatological toxicities are the most prevalent immune-related adverse events associated with immunotherapy. Herein, we report a case of a 60-year-old male who developed localized bullous pemphigoid after nearly a year of treatment with a PD-1 inhibitor, nivolumab, for metastatic renal cell carcinoma. […]
Abstract Number: 548
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Case Presentation: 90-year-old female presented with generalized weakness, nausea, vomiting, and diarrhea of 3 days duration. She also reported anorexia but denied any fever, chills, abdominal pain, chest pain, shortness of breath and cough. Vital signs were unremarkable. Physical exam was remarkable for dry oral mucous membranes, the presence of bilateral nephrostomy tubes and costovertebral […]
Abstract Number: 580
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Case Presentation: Our patient was a 58 year old male with a history of metastatic melanoma on nivolumab and ipilimumab who was directly admitted from clinic to the medicine service for increased lethargy and flu-like symptoms. The patient described a one week history of fevers/chills, headache, muscle ache, and malaise; as well as nausea, vomiting, […]
Abstract Number: 582
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Case Presentation: A 71-year-old woman with poorly differentiated squamous cell carcinoma (SCCA) of the left cheek with recent initiation of nivolumab therapy presented to the Emergency Department with five days of bilateral thigh pain, generalized weakness, and dyspnea. The exam was remarkable for tachycardia, hypotension, tachypnea as well as neck and proximal muscle strength weakness. […]
Abstract Number: 612
SHM Converge 2021
Case Presentation: The patient is a 38-year-old Caucasian female who was diagnosed with Stage IIIb malignant melanoma. The excision of the left scapular lesion and axillary dissection was performed. Baseline 18F-FDG PET scan showed no evidence of metastatic disease. After the 5th cycle of Nivolumab treatment, the patient developed 38 ºC fever and grade 2 […]